Ibnsina Pharma reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EGP 6,843.37 million compared to EGP 5,332.8 million a year ago. Net income was EGP 72.55 million compared to EGP 59.38 million a year ago.